The move to make cancer treatments gentler for children has paid a double dividend: More kids are surviving than ever before, and without the long-term complications that doomed many of their peers a generation ago, new research shows.
MARILYNN MARCHIONE AP Chief Medical Writer, San Diego Union-Tribune Nation
Sun, 05/31/2015 - 1:17pm
The move to make cancer treatments gentler for children has paid a double dividend: More kids are surviving than ever before, and without the long-term complications that doomed many of their peers a generation ago, new research shows.